Enzon Pharmaceuticals (ENZN)
Enzon Pharmaceuticals Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 10.60M | 10.01M | 10.44M | 9.599M | 18.02M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cost of Revenue | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Gross Profit | 10.60M | 10.01M | 10.44M | 9.599M | 18.02M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Research & Development Expense | 6.999M | 9.183M | 10.48M | 10.24M | 11.20M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 3.675M | 3.467M | 4.104M | 4.681M | 5.144M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 10.64M | 14.03M | 18.20M | 15.60M | 16.70M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -0.036M | -4.015M | -7.763M | -6.001M | 1.324M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | -1.035M | -1.006M | -1.142M | -1.062M | -0.893M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -1.071M | -5.021M | -8.905M | -7.063M | 0.431M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | 0.00 | 0.20M | 0.005M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Income after Tax | -1.071M | -5.021M | -9.105M | -7.068M | 0.431M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -1.071M | -5.021M | -9.105M | -7.068M | 0.431M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Net Income | -1.071M | -5.021M | -9.105M | -7.068M | 0.431M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 48.29 | 51.91 | 48.73 | 53.05 | 58.74 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 48.29 | 51.91 | 48.73 | 53.05 | 58.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.02 | -0.09 | -0.19 | -0.13 | 0.01 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.02 | -0.09 | -0.19 | -0.13 | 0.01 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
